Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06242912 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evidence Development in Cancer Treatment - Real World: PREDiCTrw

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv3
  2. Interventions: QOL (Behavioral), Radiographic or laboratory evaluation (Diagnostic Test) to QOL - quality of life (Behavioral), Radiographic or laboratory evaluation (Diagnostic Test) Secondary endpoints: details revised at 1 of 5 entries · Eligibility criteria expanded, about 3 words · Study description expanded, about 3 wordsv2 Show 3 more changesShow less
    • Secondary endpoints: details revised at 1 of 5 entries
    • Eligibility criteria expanded, about 3 words
    • Study description expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with therapy that has preliminary evidence of efficacy but uncertainty of the magnitude of clinical benefit or cost effectiveness in subjects with cancer. The goal of this study is to collect real world evidence with respect to quality of life and outcomes to support decision making.
Trial Details
NCT Number NCT06242912
Lead Sponsor British Columbia Cancer Agency
Conditions Cancer
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov